Pedro Vellosa Schwartzmann
A5049699399- Amyloidosis: Diagnosis, Treatment, Outcomes
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Parathyroid Disorders and Treatments
- Cardiac pacing and defibrillation studies
- Cardiovascular and exercise physiology
- Cardiomyopathy and Myosin Studies
- COVID-19 Clinical Research Studies
- Cardiac Imaging and Diagnostics
- Heart Rate Variability and Autonomic Control
- Erythropoietin and Anemia Treatment
- Cardiovascular Effects of Exercise
- Cardiac Arrhythmias and Treatments
- Cardiac Health and Mental Health
- Iron Metabolism and Disorders
- Mosquito-borne diseases and control
- Viral Infections and Vectors
- Long-Term Effects of COVID-19
- Atrial Fibrillation Management and Outcomes
- Public Health in Brazil
- Sarcoidosis and Beryllium Toxicity Research
- Mechanical Circulatory Support Devices
- SARS-CoV-2 and COVID-19 Research
- Transplantation: Methods and Outcomes
- Radiation Dose and Imaging
Universidade de Ribeirão Preto
2012-2025
Sociedade Brasileira de Cardiologia
2025
Clinics Hospital of Ribeirão Preto
2013-2024
Interamerican Society of Cardiology
2024
Unimed Medical Institute
2022
Universidade Estadual de Campinas (UNICAMP)
2021
Universidade de São Paulo
2010-2020
Goethe University Frankfurt
2016
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2010
Parte 1: Diretriz Brasileira de Insuficiencia Cardiaca Cronica […] e Aguda
Cardioselective β-blockade is generally well tolerated in practice and contraindications to this therapy are uncommon. β-blockers a diverse therapeutic class, their individual tolerability profiles influenced strongly by pharmacodynamic effects across different adrenergic receptors. Bisoprolol, probably the β-blocker with highest selectivity for blockade of β
Introdução A última Diretriz de Insuficiência Cardíaca do Departamento da Sociedade Brasileira Cardiologia (DEIC/SBC) foi finalizada em março 2018. partir então, houve um importante número intervenções terapêuticas e abordagens diagnósticas que surgiram ou se consolidaram na prática clínica internacional pesquisa clínica. Ao lado disso, a pandemia COVID-19 trouxe-nos conhecimento sobre o modelo fisiopatológico agressão miocárdica muitas dúvidas acerca continuidade segurança dos medicamentos...
Guidelines for the management of heart failure (HF) are evolving, and increasing emphasis is placed on patient-centred care. As part REWOLUTION HF (REal WOrLd EdUcaTION in HF) programme, we conducted two international surveys aimed at assessing healthcare professionals' (HCPs) educational needs patients' perspectives care HF.Anonymous online questionnaires co-developed by experts patients assessed HCPs' (520 respondents, mostly cardiologists, 67 countries) perceptions impact (98 respondents...
Since early 2020, different studies have shown an increased prevalence of COVID-19 and poorer prognosis in older adults with cardiovascular comorbidities. This study aimed to assess the impact heart failure (HF) on complications, intensive care unit (ICU) admissions, in-hospital mortality patients hospitalized COVID-19. The CARDIO COVID 19-20 registry includes 3260 a serological diagnosis between May 2020 June 2021 from Latin American countries. A history HF was identified 182 (5.6%). In...
1. Introduction Scientific knowledge of hypertrophic cardiomyopathy (HCM) has significantly improved in the past decades. A better understanding its pathogenesis, significant advances use imaging methods, and more common application genetic analysis, addition to a characterization natural history this myocardial disease, have profoundly reformulated clinical prognostic significance. Conversely, these processes were accompanied by development new medications addressing molecular mechanisms...
The emergence of the SARS-CoV-2 Omicron sublineages resulted in increased transmission rates and reduced protection from vaccines. To counteract these effects, multiple booster strategies were used different countries, although data comparing their efficiency improving protective immunity remain sparse, especially among vulnerable populations, including older adults. inactivated CoronaVac vaccine was most widely distributed worldwide essential early control SARS-CoV-2–related...
Background: An advanced age elevates risk for COVID-19-related cardiovascular complications and mortality. This study analyzes comorbidities outcomes in hospitalized COVID-19 patients across groups to assess its impact. Methods: The CARDIO COVID 19-20 registry is a prospective, multicenter cohort of SARS-CoV-2 44 institutions 14 Latin American countries. Patients were categorized into four groups, Group 1: under 40 years, 2: 64 3: 65 79 4: 80 years or older. Results: A total 3260 included....
The inflammatory response associated with COVID-19 varies sex, potentially affecting disease outcomes. Males have a higher risk of complications compared to females, requiring an evaluation differences in severity based on sex. To compare clinical data, biochemical biomarkers, and outcomes among hospitalized patients Latin America the Caribbean (LA&C) sex perform cluster analysis biomarker profiles for both sexes. This prospective, multicenter observational registry made by Inter-American...
1. Introdução O conhecimento médico científico sobre a cardiomiopatia hipertrófica (CMH) recebeu grande avanço nas últimas décadas. melhor entendimento da sua patogênese, os avanços expressivos no emprego dos métodos de imagem e aplicação mais corriqueira análise genética, além caracterização história natural dessa doença miocárdica, trouxeram uma profunda reformulação do seu significado clínico prognóstico. Por outro lado, esses progressos foram acompanhados desenvolvimento novas drogas...
Resumo Fundamento A patisirana reduziu rapidamente a transtirretina e preservou capacidade funcional em pacientes com amiloidose por cardiomiopatia (ATTR-CM) no estudo Fase 3 APOLLO-B (NCT03997383). Objetivos Avaliar eficácia segurança da (análise post hoc) na subpopulação brasileira do APOLLO-B. Métodos Pacientes foram randomizados 1:1 para 0,3 mg/kg ou placebo uma vez cada semanas 12 meses. O desfecho primário foi alteração relação ao período basal (ARPB) (teste de caminhada 6 minutos...
Abstract Background Patisiran rapidly knocked down transthyretin and preserved functional capacity in patients with amyloidosis cardiomyopathy (ATTR-CM) the global Phase 3 APOLLO-B study (NCT03997383). Objectives To evaluate patisiran efficacy safety post hoc analysis of Brazilian subpopulation APOLLO-B. Methods Patients were randomized 1:1 to 0.3 mg/kg or placebo every weeks for 12 months. The primary endpoint was change from baseline (CFB) (6-minute walk test [6MWT]) at Month 12. Secondary...
Resumo Fundamento A frequência cardíaca (FC) na insuficiência com fração de ejeção reduzida (ICFEr) e ritmo sinusal apresenta valor prognóstico. Entretanto, o método mensuração é debatido literatura. Objetivos Comparar em pacientes ICFEr a FC no Holter três eletrocardiogramas repouso: ECG1, ECG2 ECG3. Metodologia Estudo transversal 135 portadores ≤ 40% sinusal. foi avaliada por ECG Holter. Análises incluíram coeficiente correlação intraclasse (CCI), regressão robusta, raiz do erro quadrático...
Pneumonia bacteriana comunitária e hospitalar em adultos são problemas de saúde pública crescentes, com inúmeras internações anualmente causas frequentes morbimortalidade. A rápida caracterização do quadro clínico deve ser acompanhada decisão quanto à necessidade internação paciente o tratamento baseado na gravidade da apresentação aspectos epidemiológicos. O acompanhamento é imprescindível, tanto ambulatorialmente internação, atento aos critérios falha terapêutica revisão inicialmente...
Readmissions after an index heart failure (HF) hospitalization are a major contemporary health care problem.